fingolimod hydrochloride has been researched along with CACH Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moriya, Y; Ohnuki, T; Ryo, M; Takahashi, W; Yoshii, F | 1 |
1 other study(ies) available for fingolimod hydrochloride and CACH Syndrome
| Article | Year |
|---|---|
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
Topics: Aquaporin 4; Brain; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Leukoencephalopathies; Magnetic Resonance Imaging; Middle Aged; Neuromyelitis Optica; Spinal Cord | 2016 |